Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Midgut Neuroendocrine Tumors × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 206 Multiple Endocrine Neoplasia Type 1 129 Thyroid Cancer, Papillary 77 Pituitary Neoplasms 68 Thyroid Neoplasms 59 Pheochromocytoma 55 Carcinoma, Neuroendocrine 49 Neoplasms 48 Carcinoid Tumor 48 Carcinoma, Medullary 35 Adrenocortical Carcinoma 35 Adenocarcinoma, Follicular 34 Pancreatic Neoplasms 33 Thyroid Carcinoma, Anaplastic 30 Neoplasm Metastasis 27 Carcinoma, Non-Small-Cell Lung 27 Insulinoma 26 Breast Neoplasms 25 Paraganglioma 24 Melanoma 23 Colorectal Neoplasms 23 Colonic Neoplasms 23 Carcinoma, Renal Cell 23 Adenoma, Islet Cell 23 Somatostatinoma 22 Adrenal Gland Neoplasms 22 Sarcoma 21 Carcinoma, Islet Cell 21 Prostatic Neoplasms 20 Glucagonoma 19

Interventions

Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03667092 2025-04-10

GENEBIOLuNET

University Hospital, Toulouse

Phase NA Completed

Midgut Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡